GlassScriptPhysician profile
Lucia A Dangelo
NPI 1699864470
$5,602.92
in general payments reported to CMS, 2019-2025
10 companies · $4,731 in 2025
The $4,731 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.95 · 2020: $36.64 · 2022: $21.15 · 2023: $37.20 · 2024: $731 · 2025: $4,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,417 · Food and Beverage: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,416.54 |
| Food and Beverage | $1,082.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $4,416.54 | 2025 | |
| Alcon Vision LLC | $390.25 | 2023-2025 | Total30, Precision7, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $244.58 | 2024-2025 | Acuvue |
| Tarsus Pharmaceuticals, INC. | $200.46 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $144.47 | 2024 | Infuse |
| Coopervision INC. | $102.88 | 2025 | Clariti Contact Lens |
| Genentech USA, INC. | $45.95 | 2019 | |
| Sun Pharmaceutical Industries INC. | $21.15 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucia Dangelo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.